TG THERAPEUTICS, INC. — Director's Dealing 2023

Jan 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TG THERAPEUTICS, INC. (TGTX)
CIK: 0001001316
Period of Report: 2023-01-04

Reporting Person: Charney Laurence N (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-04	Common Stock	S	30000	$11.10	Disposed	234729	Direct

Footnotes

F1: In connection with the vesting of 100,878 shares on January 1, 2023, 30,000 shares were sold in order to cover the reporting person's income tax obligations.

F2: Reflects the weighted average sale price. The range of prices for the shares sold was $10.91 to $11.38. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Includes shares of restricted Common Stock, which vest over various time periods.